Notícias Eulerpool Oxford Biodynamics

Oxford Biodynamics Eulerpool-AFX

Oxford Biodynamics Notícias de ações

Oxford Biodynamics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Oxford Biodynamics nós reunimos aqui.

• 4 de junho ·

  Yahoo
  Oxford BioDynamics Develops a High Accuracy, Discriminating Diagnostic Test for Multiple Canine Cancers
• 18 de janeiro ·

  Yahoo
  Is Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?
• 18 de outubro ·

  Yahoo
  Bupa UK to cover EpiSwitch® CiRT for customers with cancer
• 3 de outubro ·

  Yahoo
  Oxford BioDynamics Receives Reimbursement Code for EpiSwitch® Prostate Screening (PSE) Test
• 26 de setembro ·

  Yahoo
  Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch® Prostate Screening Blood Test to Men With Prostate Cancer Risk
• 4 de setembro ·

  Yahoo
  Several Insiders Invested In Oxford BioDynamics Flagging Positive News
• 6 de fevereiro ·

  Yahoo
  Oxford BioDynamics’ Prostate Screening EpiSwitch® Blood Test Significantly Enhances Overall Detection Accuracy For At Risk Men
• 2 de fevereiro ·

  Yahoo
  The Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More Shares
• 29 de janeiro ·

  Yahoo
  Oxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)
• 19 de dezembro ·

  Yahoo
  Oxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare Conference